1401 - Bladder Cancer: Vaccination (Answered)

Mr Iain Wright
To ask the Secretary of State for Health, what steps he has taken to increase the supply of the BCG vaccine for the treatment of patients affected by bladder cancer; and if he will make a statement.

George Freeman

The supply problems with Bacillus Calmette-Guérin (BCG) bladder instillations are affecting countries worldwide, and have arisen due to manufacturing problems. One of the two United Kingdom licensed BCG bladder instillations has been unavailable since 2012, and the manufacturer of the other has increased its production as far as possible to help meet the shortfall. The Department and the Medicines and Healthcare products Regulatory Agency are working closely with both suppliers, as well as others in the supply chain, to ensure that everything possible is being done to make supplies available for patients who need this treatment. The Department has also been in close contact with the British Association of Urological Surgeons who have issued advice for clinicians.